Adherence rate, barriers to attend, safety and overall experience of a physical exercise program via telemonitoring during COVID-19 pandemic for individuals with Parkinson's disease: A feasibility study.
COVID-19
Parkinson's disease
barriers
physical activity
physical exercise
sedentary behavior
social isolation
telemonitoring
telerehabilitation
Journal
Physiotherapy research international : the journal for researchers and clinicians in physical therapy
ISSN: 1471-2865
Titre abrégé: Physiother Res Int
Pays: United States
ID NLM: 9612022
Informations de publication
Date de publication:
Oct 2022
Oct 2022
Historique:
revised:
30
03
2022
received:
17
11
2021
accepted:
07
05
2022
pubmed:
29
5
2022
medline:
5
10
2022
entrez:
28
5
2022
Statut:
ppublish
Résumé
Telemonitoring can maintain daily exercise routine during the COVID-19 pandemic of individuals with Parkinson's disease (PD). However, there are barriers to adherence and attendance with remote physical rehabilitation. The main objective of this study was to evaluate adherence rate, barriers to attendance, and safety of a telemonitoring program for individuals with PD; and secondarily to evaluate the individual and their family members perceived overall experience when performing the telemonitoring physical exercise program. This was a phase 1 of a clinical trial, engaging 19 individuals with idiopathic PD of an in-person community rehabilitation program. For 24 weeks an asynchronous telemonitoring physical exercise program delivered two sessions per week by video including warm-up, balance, aerobic and resistance exercises, and cool-down. During the remote program were verified: adherence rate at entrance, attendance rate, barriers to attend, safety, and overall experience of the program. Only one participant did not perform any session and 18 participants completed between 2 and 34 sessions. Participants with a caregiver showed higher attendance rates. The most frequently cited barriers to attend the program were: pain; lack of motor skills; and reduced physical fitness. In relation to safety of the program, the most frequently reported was fear of falling. Although participants reported the telemonitoring program induced health benefits and they had positive experiences for themselves and for their families, most of participants prefer an in-person program. In this sense, the asynchronous telemonitoring physical exercise program was safe, showed moderate adherence, with attendance rate depending on the presence of a companion.
Sections du résumé
BACKGROUND
BACKGROUND
Telemonitoring can maintain daily exercise routine during the COVID-19 pandemic of individuals with Parkinson's disease (PD). However, there are barriers to adherence and attendance with remote physical rehabilitation. The main objective of this study was to evaluate adherence rate, barriers to attendance, and safety of a telemonitoring program for individuals with PD; and secondarily to evaluate the individual and their family members perceived overall experience when performing the telemonitoring physical exercise program.
METHODS
METHODS
This was a phase 1 of a clinical trial, engaging 19 individuals with idiopathic PD of an in-person community rehabilitation program. For 24 weeks an asynchronous telemonitoring physical exercise program delivered two sessions per week by video including warm-up, balance, aerobic and resistance exercises, and cool-down. During the remote program were verified: adherence rate at entrance, attendance rate, barriers to attend, safety, and overall experience of the program.
RESULTS AND CONCLUSION
CONCLUSIONS
Only one participant did not perform any session and 18 participants completed between 2 and 34 sessions. Participants with a caregiver showed higher attendance rates. The most frequently cited barriers to attend the program were: pain; lack of motor skills; and reduced physical fitness. In relation to safety of the program, the most frequently reported was fear of falling. Although participants reported the telemonitoring program induced health benefits and they had positive experiences for themselves and for their families, most of participants prefer an in-person program. In this sense, the asynchronous telemonitoring physical exercise program was safe, showed moderate adherence, with attendance rate depending on the presence of a companion.
Identifiants
pubmed: 35633094
doi: 10.1002/pri.1959
pmc: PMC9348085
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e1959Informations de copyright
© 2022 John Wiley & Sons Ltd.
Références
Psychol Rev. 1977 Mar;84(2):191-215
pubmed: 847061
Int J Technol Assess Health Care. 2020 Apr;36(2):113-125
pubmed: 32151291
Phys Ther. 2020 Aug 12;100(8):1278-1288
pubmed: 32372072
Front Psychol. 2021 Jul 09;12:647883
pubmed: 34305716
Gait Posture. 2018 Mar;61:311-319
pubmed: 29413803
Disabil Rehabil. 2020 May;42(9):1270-1274
pubmed: 30621467
Gait Posture. 2009 Nov;30(4):459-63
pubmed: 19660949
J Autoimmun. 2020 May;109:102433
pubmed: 32113704
Phys Ther. 2020 Sep 28;100(10):1730-1736
pubmed: 32734298
JMIR Mhealth Uhealth. 2020 Oct 5;8(10):e18985
pubmed: 33016887
Mov Disord. 2004 Sep;19(9):1020-8
pubmed: 15372591
Curr Opin Neurol. 2021 Aug 1;34(4):589-597
pubmed: 33990100
Prog Neuropsychopharmacol Biol Psychiatry. 2018 Dec 20;87(Pt B):200-206
pubmed: 29031913
Mov Disord. 2020 May;35(5):711-715
pubmed: 32250460
Neurodegener Dis Manag. 2016 Oct;6(5):431-46
pubmed: 27599588
J Parkinsons Dis. 2017;7(4):703-711
pubmed: 29103050
Physiother Res Int. 2022 Oct;27(4):e1959
pubmed: 35633094
J Neurol. 2009 May;256(5):742-9
pubmed: 19240961
PLoS One. 2019 Nov 12;14(11):e0225150
pubmed: 31714924
Eur J Neurol. 2018 Jul;25(7):917-e69
pubmed: 29520899
PLoS One. 2016 Apr 28;11(4):e0154335
pubmed: 27124611
J Parkinsons Dis. 2020;10(2):351-354
pubmed: 32250324
Phys Ther. 2019 Feb 1;99(2):203-216
pubmed: 30715489
Psychogeriatrics. 2020 Jan;20(1):20-27
pubmed: 30912230
Phys Ther. 2022 Apr 1;102(4):
pubmed: 34963139
Complement Ther Med. 2018 Dec;41:320-327
pubmed: 30477861
Neurology. 2010 Nov 9;75(19):1717-25
pubmed: 21060094
Aging Clin Exp Res. 2021 Feb;33(2):221-246
pubmed: 32514871
Ann Palliat Med. 2020 Feb;9(Suppl 1):S75-S79
pubmed: 31865746